HIV-Selectest enzyme immunoassay and rapid test: Ability to detect seroconversion following HIV-1 infection

Surender Khurana, Philip J. Norris, Michael P. Busch, Barton F. Haynes, Susan Park, Pretty Sasono, Koleka Mlisana, Abdool Karim Salim, Frederick M. Hecht, Joseph Mulenga, Elwyn Chomba, Eric Hunter, Susan Allen, George Nemo, Isaac R. Rodriguez-Chavez, Joseph B. Margolick, Hana Golding

Research output: Contribution to journalComment/debatepeer-review

5 Scopus citations

Abstract

HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.

Original languageEnglish (US)
Pages (from-to)281-285
Number of pages5
JournalJournal of clinical microbiology
Volume48
Issue number1
DOIs
StatePublished - Jan 2010

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'HIV-Selectest enzyme immunoassay and rapid test: Ability to detect seroconversion following HIV-1 infection'. Together they form a unique fingerprint.

Cite this